ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Davisite
|
34 |
9.8K |
63 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
34
|
9.8K
|
63
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
7 |
20/07/24 |
20/07/24 |
General
|
11K
|
3.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
21K |
7.6M |
35 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
21K
|
7.6M
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
5 |
20/07/24 |
20/07/24 |
General
|
11K
|
3.9M
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
9 |
20/07/24 |
20/07/24 |
General
|
11K
|
3.9M
|
9
|
|
ASX - By Stock
|
SIS |
Re:
Ann: Annual General Meeting Address and Presentation
|
|
Davisite
|
35 |
11K |
3 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
35
|
11K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Davisite
|
389 |
164K |
27 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
389
|
164K
|
27
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
21K |
7.6M |
20 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.6M
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Davisite
|
389 |
164K |
22 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
389
|
164K
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
64 |
19/07/24 |
19/07/24 |
General
|
11K
|
3.9M
|
64
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
21K |
7.6M |
33 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21K
|
7.6M
|
33
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
10 |
18/07/24 |
18/07/24 |
General
|
11K
|
3.9M
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
16 |
18/07/24 |
18/07/24 |
General
|
11K
|
3.9M
|
16
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
44 |
18/07/24 |
18/07/24 |
General
|
11K
|
3.9M
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
26 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
42K
|
26
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
32 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
32
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
38 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
38
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
11 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
30 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
30
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Davisite
|
60 |
20K |
33 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
20K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
58 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
42K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
30 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
42K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
20 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
42K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
26 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
42K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
32 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
42K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Davisite
|
146 |
42K |
72 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
42K
|
72
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
38 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
47K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
40 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
47K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
42 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
80K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
35 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
80K
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
65 |
09/07/24 |
09/07/24 |
General
|
11K
|
3.9M
|
65
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
28 |
09/07/24 |
09/07/24 |
General
|
11K
|
3.9M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
40 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
24 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
58 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
29 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
44 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
21 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Davisite
|
905 |
266K |
37 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
905
|
266K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
38 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Davisite
|
391 |
80K |
34 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
80K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
19 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
168
|
47K
|
19
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Change of Director's Interest Notice - Peter Molloy
|
|
Davisite
|
4 |
2.4K |
11 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
4
|
2.4K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
29 |
05/07/24 |
05/07/24 |
General
|
11K
|
3.9M
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
42 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
42
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
25 |
05/07/24 |
05/07/24 |
General
|
11K
|
3.9M
|
25
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
11K |
3.9M |
83 |
05/07/24 |
05/07/24 |
General
|
11K
|
3.9M
|
83
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
19 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
51 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Davisite
|
168 |
47K |
84 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
84
|
|